Aminexil INCI Name, Diaminopyrimidine Oxide and Kopexil: A B2B Buyer's Naming Guide

The INCI name commonly associated with Aminexil is Diaminopyrimidine Oxide. In B2B sourcing and formulation work, Aminexil is widely used as a market name, while Diaminopyrimidine Oxide serves as the basis for ingredient identity and documentation review. For procurement teams, formulators, and QA and regulatory reviewers working across international markets, aligning these names consistently across product pages, COA, SDS/MSDS, specification sheets, and internal purchasing records is a practical priority.

1. What Is the INCI Name of Aminexil?

Aminexil is a market name that has become widely recognized in the scalp-care ingredient space. Its corresponding INCI name, the standardized nomenclature used in cosmetic ingredient labeling, is Diaminopyrimidine Oxide. Buyers may also encounter the synonym Kopexil in supplier catalogues, trade documentation, or formulation databases.

The table below summarizes the key identity information a B2B buyer should confirm when reviewing supplier documentation.

When requesting documentation from a supplier, buyers should verify that the market name, INCI name, and CAS number are all consistently represented across the COA, SDS/MSDS, and specification sheet.

2. Aminexil vs Diaminopyrimidine Oxide vs Kopexil

These three names refer to the same ingredient identity, but they appear in different contexts and serve different purposes in B2B communication.

1. Aminexil is a market name that appears frequently in brand communications, product descriptions, and formulation literature. It is recognizable but is not an INCI-standard term.
2. Diaminopyrimidine Oxide is the INCI name. It is used in ingredient declarations, regulatory filings, formulation documentation, and QA review processes. Buyers working on products intended for markets that require INCI-compliant labeling should expect to see this name in their supplier documentation.
3. Kopexil is a synonym that may appear in certain supplier catalogues or technical databases. It refers to the same ingredient but should be treated as an alternative trade reference rather than a primary regulatory identifier.

When comparing suppliers or reviewing multiple source documents, buyers should confirm that all three names are being used to describe the same substance by cross-referencing the CAS number (74638-76-9) and reviewing the specification sheet for purity and assay information.

3. How Aminexil May Appear in an Ingredient List

In finished cosmetic products, ingredients are typically declared using their INCI names. Buyers and formulators sourcing this ingredient for scalp serums, tonics, ampoules, or leave-on scalp-care formulations should expect Diaminopyrimidine Oxide to appear in the ingredient declaration rather than the market name Aminexil.

During formulation review, it is advisable to verify with the supplier that the raw material supplied under the Aminexil market name is documented with the corresponding INCI name and CAS number. This cross-referencing supports both internal formula documentation and downstream labeling review.

For buyers operating in regulated markets, confirming ingredient identity through the INCI name and CAS number, rather than relying on market names alone, is standard practice for both procurement and regulatory preparation.

4. Why Naming Consistency Matters for B2B Buyers

Inconsistent naming across sourcing and formulation workflows can create delays and documentation gaps at several points in the procurement and product development process.

1. Procurement review: Purchase orders and supplier agreements should reference the ingredient by a consistent name, ideally INCI name with CAS number, to reduce ambiguity when comparing quotes from multiple suppliers.
2. QA review: Quality teams typically verify incoming raw materials against established specifications. If the market name used during sourcing does not match the INCI name or CAS number listed in the COA, additional confirmation steps may be required.
3. Regulatory review: For products entering markets with defined ingredient disclosure requirements, using the INCI name in formula records ensures that ingredient declarations are prepared accurately and efficiently.
4. Supplier comparison: When evaluating multiple Aminexil / Diaminopyrimidine Oxide suppliers, buyers should compare documentation using a consistent identifier, the INCI name and CAS number, rather than market names, which may vary by supplier.
5. Document archiving: Internal formula records, supplier qualification files, and batch documentation are easier to manage and audit when ingredient names are standardized across all documents.
6. Formula development communication: Formulators and brand teams working together benefit from a shared naming convention. Establishing early whether communications will use the market name or INCI name reduces confusion during development reviews.

5. What Documents Should Buyers Request from an Aminexil Supplier?

When initiating a sourcing inquiry for Aminexil / Diaminopyrimidine Oxide, buyers should request the following documentation as part of their standard supplier qualification process.

1. Certificate of Analysis (COA): Confirms ingredient identity, purity, and compliance with the specification for a given batch. Should reference INCI name and CAS number.
2. Safety Data Sheet (SDS / MSDS): Provides handling, storage, and safety information. Required for internal compliance and logistics review in most markets.
3. Specification Sheet: Outlines physical and chemical properties, purity or assay range, typical usage parameters, and packaging options.
4. Purity or assay information: Buyers should confirm the active content and any relevant certificate data, particularly if the ingredient will be used at a defined concentration in a formulation.
5. Batch information: For traceability and quality audit purposes, batch numbers and production records should be available upon request.
6. Sample support: Qualifying a new supplier typically requires a sample for internal formulation testing. Buyers should clarify sample quantity, format, and lead time.
7. Lead time and MOQ: Understanding minimum order quantities and production or delivery timelines supports planning at both the procurement and formulation stages.
8. Bulk quotation: For ongoing supply arrangements or initial project budgeting, a formal quotation based on target quantity and destination market is standard practice.

6. Questions to Ask Before Sourcing Aminexil / Diaminopyrimidine Oxide

The following questions can guide buyer conversations during supplier evaluation.

1. Is the ingredient identity, INCI name and CAS number, listed consistently across all documents, including the COA, SDS/MSDS, and specification sheet?
2. Can the supplier provide a current COA and SDS/MSDS for the offered batch?
3. What sample quantities are available, and what is the lead time for sample dispatch?
4. What are the minimum order quantity (MOQ) and standard lead time for bulk orders?
5. Can the supplier support OEM/ODM formulation discussions or provide application guidance for scalp-care formats such as serums, tonics, or ampoules?
6. Can documentation be prepared or formatted to support internal QA review or regulatory submission requirements in the target market?

7. How WUMO Lab Supports Aminexil B2B Inquiries

WUMO Lab supports sourcing inquiries for Aminexil / Diaminopyrimidine Oxide for use in scalp-care formulation projects. Buyers may review the Aminexil (Diaminopyrimidine Oxide) supplier page or request the following through WUMO Lab's B2B inquiry process:

1. COA and SDS/MSDS documentation
2. Specification sheet and purity information
3. Sample support for formulation evaluation
4. Bulk quotation based on target quantity and destination market
5. OEM/ODM project discussion for custom scalp-care formulations

To initiate a sourcing inquiry, buyers are welcome to share their target quantity, application format, such as scalp serum, tonic, or ampoule, documentation requirements, and destination market. WUMO Lab's team can support these discussions at both the ingredient sourcing and formulation planning stages. Buyers can request COA and SDS/MSDS documents or use the B2B contact channel for sample availability, MOQ, lead time, and quotation discussion.

If the project involves broader product planning, buyers may also review WUMO Lab's scalp-care formulation projects context or OEM/ODM formulation support path.

Frequently Asked Questions

1. What is the INCI name of Aminexil?

The INCI name of Aminexil is Diaminopyrimidine Oxide. This is the standardized name used in cosmetic ingredient declarations, regulatory documentation, and formulation records.

2. Is Aminexil the same as Diaminopyrimidine Oxide?

Yes. Aminexil is the market name, while Diaminopyrimidine Oxide is the corresponding INCI name. Both refer to the same ingredient, identified by CAS No. 74638-76-9. Buyers should confirm this alignment when reviewing supplier documentation.

3. What is Kopexil?

Kopexil is a synonym for the same ingredient. It may appear in supplier catalogues or technical databases alongside or instead of the names Aminexil or Diaminopyrimidine Oxide. Buyers should cross-reference the CAS number (74638-76-9) to confirm ingredient identity when any of these names are used.

4. How does Aminexil appear in an ingredient list?

In finished cosmetic products, the ingredient is typically declared using its INCI name: Diaminopyrimidine Oxide. The market name Aminexil is not an INCI-standard term and would not normally appear in a product's ingredient declaration.

5. What documents should I request before buying Aminexil?

Buyers should request a COA, SDS/MSDS, and specification sheet as a minimum. Additional documentation may include batch records, purity or assay data, and sample availability confirmation. For import or regulatory purposes, buyers should clarify documentation format requirements with their supplier.

6. Can WUMO Lab provide COA and SDS/MSDS for Aminexil?

Yes. WUMO Lab can provide COA and SDS/MSDS documentation for Aminexil / Diaminopyrimidine Oxide as part of a sourcing inquiry. Buyers may also request a specification sheet and sample support through WUMO Lab's B2B contact channel

7. Can Aminexil / Diaminopyrimidine Oxide be used in scalp-care formulations?

Diaminopyrimidine Oxide is commonly incorporated into scalp-care formulations including serums, tonics, ampoules, and leave-on scalp-care products. For specific formulation guidance, application concentration, or OEM/ODM project support, buyers are encouraged to contact WUMO Lab with their formulation requirements.

Request Documentation or a Bulk Quotation

For Aminexil / Diaminopyrimidine Oxide sourcing inquiries, contact WUMO Lab to request:

1. COA and SDS/MSDS documentation
2. Specification sheet
3. Sample availability and dispatch details
4. MOQ and lead time information
5. Bulk quotation based on your target quantity and destination market

Submit your inquiry at peptide.wumolab.com or reach out directly to WUMO Lab's B2B team with your formulation requirements, documentation needs, and project timeline.